HUE071193T2 - Sejtek transzfekció utáni korai izolálása (EPIC) biologikumok elõállításához - Google Patents
Sejtek transzfekció utáni korai izolálása (EPIC) biologikumok elõállításáhozInfo
- Publication number
- HUE071193T2 HUE071193T2 HUE16788603A HUE16788603A HUE071193T2 HU E071193 T2 HUE071193 T2 HU E071193T2 HU E16788603 A HUE16788603 A HU E16788603A HU E16788603 A HUE16788603 A HU E16788603A HU E071193 T2 HUE071193 T2 HU E071193T2
- Authority
- HU
- Hungary
- Prior art keywords
- epic
- biologics
- cells
- production
- early post
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
- G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1086—Preparation or screening of expression libraries, e.g. reporter assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N15/149—Optical investigation techniques, e.g. flow cytometry specially adapted for sorting particles, e.g. by their size or optical properties
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70592—CD52
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Food Science & Technology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Bioinformatics & Computational Biology (AREA)
- Dispersion Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Epoxy Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562239515P | 2015-10-09 | 2015-10-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE071193T2 true HUE071193T2 (hu) | 2025-08-28 |
Family
ID=57211576
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE16788603A HUE071193T2 (hu) | 2015-10-09 | 2016-10-07 | Sejtek transzfekció utáni korai izolálása (EPIC) biologikumok elõállításához |
| HUE16788602A HUE069884T2 (hu) | 2015-10-09 | 2016-10-07 | Javított flare (áramlási citometriával csillapított reporter expresszió) technológia gyors tömeges válogatáshoz |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE16788602A HUE069884T2 (hu) | 2015-10-09 | 2016-10-07 | Javított flare (áramlási citometriával csillapított reporter expresszió) technológia gyors tömeges válogatáshoz |
Country Status (12)
| Country | Link |
|---|---|
| US (4) | US10317329B2 (hu) |
| EP (4) | EP4530350A3 (hu) |
| CN (3) | CN108368504B (hu) |
| AU (3) | AU2016335699A1 (hu) |
| CA (2) | CA3001364A1 (hu) |
| ES (2) | ES3008383T3 (hu) |
| HU (2) | HUE071193T2 (hu) |
| IL (4) | IL309289A (hu) |
| MX (1) | MX2018004366A (hu) |
| PL (2) | PL3359665T3 (hu) |
| SG (3) | SG10202111233SA (hu) |
| WO (2) | WO2017062722A2 (hu) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3151866B1 (en) | 2014-06-09 | 2023-03-08 | Voyager Therapeutics, Inc. | Chimeric capsids |
| KR20170096998A (ko) | 2014-11-05 | 2017-08-25 | 보이저 테라퓨틱스, 인크. | 파킨슨병의 치료를 위한 aadc 폴리뉴클레오티드 |
| WO2016077689A1 (en) | 2014-11-14 | 2016-05-19 | Voyager Therapeutics, Inc. | Modulatory polynucleotides |
| WO2016077687A1 (en) | 2014-11-14 | 2016-05-19 | Voyager Therapeutics, Inc. | Compositions and methods of treating amyotrophic lateral sclerosis (als) |
| WO2016094783A1 (en) | 2014-12-12 | 2016-06-16 | Voyager Therapeutics, Inc. | Compositions and methods for the production of scaav |
| EP4530350A3 (en) | 2015-10-09 | 2025-06-25 | Genzyme Corporation | Improved flare (flow cytometry attenuated reporter expression) technology for rapid bulk sorting |
| EP3448874A4 (en) | 2016-04-29 | 2020-04-22 | Voyager Therapeutics, Inc. | COMPOSITIONS FOR TREATING A DISEASE |
| EP3448987A4 (en) | 2016-04-29 | 2020-05-27 | Voyager Therapeutics, Inc. | COMPOSITIONS FOR TREATING A DISEASE |
| BR112018073472A2 (pt) | 2016-05-18 | 2019-08-27 | Voyager Therapeutics Inc | composições e métodos de tratamento da doença de huntington |
| CA3024448C (en) | 2016-05-18 | 2025-09-09 | Voyager Therapeutics, Inc. | MODULATING POLYNUCLEOTIDES |
| CL2016001661A1 (es) | 2016-06-29 | 2017-03-03 | Univ Chile | Promotor hibrido de ß-actina (de cricetulus griseus) y citomegalovirus (cmv), con región rica en dinucleótidos, citosina-guanina, vectores, líneas celulares, procedimiento para producir proteínas recombinantes. |
| JP2019531787A (ja) | 2016-08-30 | 2019-11-07 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 生物医学的ターゲティング及びデリバリーの方法並びにそれを実行するための装置及びシステム |
| SG11201903018WA (en) | 2016-10-07 | 2019-05-30 | Genzyme Corp | Early post-transfection isolation of cells (epic) for biologics production |
| SG11201909868YA (en) | 2017-05-05 | 2019-11-28 | Voyager Therapeutics Inc | Compositions and methods of treating huntington's disease |
| WO2018204786A1 (en) | 2017-05-05 | 2018-11-08 | Voyager Therapeutics, Inc. | Compositions and methods of treating amyotrophic lateral sclerosis (als) |
| JOP20190269A1 (ar) | 2017-06-15 | 2019-11-20 | Voyager Therapeutics Inc | بولي نوكليوتيدات aadc لعلاج مرض باركنسون |
| CA3070087A1 (en) | 2017-07-17 | 2019-01-24 | Voyager Therapeutics, Inc. | Trajectory array guide system |
| CA3075656A1 (en) | 2017-09-29 | 2019-04-04 | Voyager Therapeutics, Inc. | Rescue of central and peripheral neurological phenotype of friedreich's ataxia by intravenous delivery |
| WO2019079240A1 (en) | 2017-10-16 | 2019-04-25 | Voyager Therapeutics, Inc. | TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS) |
| EP4454654A3 (en) | 2017-10-16 | 2025-02-19 | Voyager Therapeutics, Inc. | Treatment of amyotrophic lateral sclerosis (als) |
| JP2021523914A (ja) | 2018-05-15 | 2021-09-09 | ボイジャー セラピューティクス インコーポレイテッドＶｏｙａｇｅｒ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． | パーキンソン病を治療するための組成物および方法 |
| JP7528066B2 (ja) | 2018-09-28 | 2024-08-05 | ボイジャー セラピューティクス インコーポレイテッド | 操作されたプロモータを有するフラタキシン発現コンストラクトおよびその使用方法 |
| KR20230109683A (ko) | 2020-11-19 | 2023-07-20 | 젠자임 코포레이션 | 유세포 분석 감쇠 리포터 발현(플레어) 다중 리포터 시스템 및 이의 사용 방법 |
| US20250281605A1 (en) | 2024-03-08 | 2025-09-11 | Sanofi | Antigenic Epstein Barr Virus Polypeptides |
Family Cites Families (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4818700A (en) | 1985-10-25 | 1989-04-04 | Phillips Petroleum Company | Pichia pastoris argininosuccinate lyase gene and uses thereof |
| US4812405A (en) | 1986-02-18 | 1989-03-14 | Phillips Petroleum Company | Double auxotrophic mutants of Pichia pastoris and methods for preparation |
| US4937190A (en) | 1987-10-15 | 1990-06-26 | Wisconsin Alumni Research Foundation | Translation enhancer |
| US4929555A (en) | 1987-10-19 | 1990-05-29 | Phillips Petroleum Company | Pichia transformation |
| AU6067590A (en) | 1989-07-24 | 1991-02-22 | Seragen, Inc. | Prevention of internal initiation |
| US5648267A (en) | 1992-11-13 | 1997-07-15 | Idec Pharmaceuticals Corporation | Impaired dominant selectable marker sequence and intronic insertion strategies for enhancement of expression of gene product and expression vector systems comprising same |
| WO1994026087A2 (en) | 1993-05-14 | 1994-11-24 | Connor Kim C O | Recombinant protein production and insect cell culture and process |
| US5429746A (en) | 1994-02-22 | 1995-07-04 | Smith Kline Beecham Corporation | Antibody purification |
| US7252989B1 (en) | 1994-04-04 | 2007-08-07 | Board Of Regents, The University Of Texas System | Adenovirus supervector system |
| US5955349A (en) | 1996-08-26 | 1999-09-21 | Zymogenetics, Inc. | Compositions and methods for producing heterologous polypeptides in Pichia methanolica |
| US5736383A (en) | 1996-08-26 | 1998-04-07 | Zymogenetics, Inc. | Preparation of Pichia methanolica auxotrophic mutants |
| EP1012268A4 (en) | 1997-02-25 | 2001-11-28 | Qbi Entpr Ltd | IRES SEQUENCES WITH HIGH TRANSLATION EFFICIENCY AND EXPRESSION VECTORS CONTAINING THEM |
| US7001733B1 (en) * | 1998-05-12 | 2006-02-21 | Rigel Pharmaceuticals, Inc. | Methods and compositions for screening for modulations of IgE synthesis, secretion and switch rearrangement |
| US6258559B1 (en) | 1999-03-22 | 2001-07-10 | Zymogenetics, Inc. | Method for producing proteins in transformed Pichia |
| US20050005310A1 (en) * | 1999-07-12 | 2005-01-06 | Genentech, Inc. | Expression vectors and methods |
| JP2003504059A (ja) * | 1999-07-12 | 2003-02-04 | ジェネンテック・インコーポレーテッド | 発現ベクターと方法 |
| WO2001057212A1 (en) | 2000-02-02 | 2001-08-09 | Iconix Pharmaceuticals, Inc. | Rapid, parallel identification of cell lines |
| US6833254B2 (en) | 2001-03-01 | 2004-12-21 | The Regents Of The University Of California | Method to identify IRES elements |
| DE10143237A1 (de) | 2001-09-04 | 2003-03-20 | Icon Genetics Ag | Herstellung künstlicher interner ribosomaler Eingangsstellenelemente (Ires-Elemente) |
| DE10143238A1 (de) | 2001-09-04 | 2003-03-20 | Icon Genetics Ag | Identifizierung eukaryotischer interner Ribosomen-Eingangsstellen (IRES)-Elemente |
| NZ552851A (en) | 2002-05-22 | 2008-09-26 | Biogen Idec Inc | Detection of a secreted polypeptide on the surface of a cell used as a marker for cellular productivity of the secreted polypeptide |
| US7119187B2 (en) | 2002-07-09 | 2006-10-10 | National Health Research Institutes | Internal ribosome entry site of the labial gene for protein expression |
| GB0216648D0 (en) | 2002-07-18 | 2002-08-28 | Lonza Biologics Plc | Method of expressing recombinant protein in CHO cells |
| EP1540008A4 (en) * | 2002-07-19 | 2006-04-12 | Diversa Corp | FLUORESCENT PROTEINS, NUCLEIC ACIDS ENCODING THEM, AND METHODS OF MAKING AND USING SAME |
| US7384744B2 (en) * | 2002-11-29 | 2008-06-10 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | Expression vector, methods for the production of heterologous gene products and for the selection of recombinant cells producing high levels of such products |
| US7344886B2 (en) | 2002-11-29 | 2008-03-18 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | Neomycin-phosphotransferase-genes and methods for the selection of recombinant cells producing high levels of a desired gene product |
| AU2003300932A1 (en) | 2002-12-16 | 2004-07-29 | Wayne State University | Bioactive peptides and unique ires elements from myelin proteolipid protein plp/dm20 |
| EP3346010A1 (en) | 2003-06-24 | 2018-07-11 | Genzyme Corporation | Novel beta-actin and rps21 promoters and uses thereof |
| US7776584B2 (en) | 2003-08-01 | 2010-08-17 | Genetix Limited | Animal cell colony picking apparatus and method |
| US20070178072A1 (en) | 2004-03-31 | 2007-08-02 | Kirin Beer Kabushiki Kaisha | Method for inducing differentiation of regulatory t cells usinggip-anchored protein agonist and pharmaceutical composition therefor ( as amended |
| US7078179B2 (en) | 2004-05-04 | 2006-07-18 | Newlink Genetics Corporation | Selectable gene marker system based on expression of N-acetyllactosaminide 3-α galactosyltransferase |
| WO2006023248A2 (en) * | 2004-07-28 | 2006-03-02 | The Trustees Of Columbia University In The City Of New York | Processes for producing and crystallizing g-protein coupled receptors |
| SI1809750T1 (sl) | 2004-11-08 | 2012-08-31 | Chromagenics Bv | Izbira gostiteljskih celic, ki imajo visok nivo izraĹľanja proteina |
| JP5291341B2 (ja) | 2004-11-08 | 2013-09-18 | クロマジェニックス ベー ヴェー | タンパク質を高レベルで発現する宿主細胞の選定 |
| US20080248468A1 (en) | 2004-12-14 | 2008-10-09 | Manfred Kubbies | Method for Improved Selection of Rnai Transfectants |
| WO2007118208A2 (en) | 2006-04-10 | 2007-10-18 | The Regents Of The University Of California | Systems for collection of single cells and colonies |
| PT2064337E (pt) | 2006-09-20 | 2012-07-26 | Genzyme Corp | Sistema à base de facs e proteína repórter para o desenvolvimento de elevado desempenho de proteínas terapêuticas |
| CA2679393A1 (en) | 2007-03-05 | 2008-09-12 | Newsouth Innovations Pty Limited | Methods for detecting and modulating the sensitivity of tumour cells to anti-mitotic agents |
| WO2012001073A2 (en) | 2010-07-01 | 2012-01-05 | Glaxo Group Limited | Improved method for selecting high producing cell lines |
| AU2013243952A1 (en) * | 2012-04-02 | 2014-10-30 | Modernatx, Inc. | Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins |
| EP2700713B1 (en) * | 2012-08-21 | 2016-07-13 | Miltenyi Biotec GmbH | Screening and enrichment system for protein expression in eukaryotic cells using a tricistronic expression cassette |
| EP2970956A1 (en) * | 2013-03-11 | 2016-01-20 | Novartis AG | Method of screening cell clones |
| PL3027646T3 (pl) * | 2013-07-31 | 2019-03-29 | Novartis Ag | Nowe wektory selekcyjne i sposoby selekcji eukariotycznych komórek gospodarza |
| EP4530350A3 (en) | 2015-10-09 | 2025-06-25 | Genzyme Corporation | Improved flare (flow cytometry attenuated reporter expression) technology for rapid bulk sorting |
| SG11201903018WA (en) | 2016-10-07 | 2019-05-30 | Genzyme Corp | Early post-transfection isolation of cells (epic) for biologics production |
-
2016
- 2016-10-07 EP EP24212463.4A patent/EP4530350A3/en active Pending
- 2016-10-07 ES ES16788602T patent/ES3008383T3/es active Active
- 2016-10-07 HU HUE16788603A patent/HUE071193T2/hu unknown
- 2016-10-07 IL IL309289A patent/IL309289A/en unknown
- 2016-10-07 HU HUE16788602A patent/HUE069884T2/hu unknown
- 2016-10-07 SG SG10202111233SA patent/SG10202111233SA/en unknown
- 2016-10-07 CA CA3001364A patent/CA3001364A1/en active Pending
- 2016-10-07 IL IL297805A patent/IL297805A/en unknown
- 2016-10-07 EP EP25158011.4A patent/EP4567425A3/en active Pending
- 2016-10-07 US US15/288,050 patent/US10317329B2/en active Active
- 2016-10-07 CN CN201680071815.6A patent/CN108368504B/zh active Active
- 2016-10-07 EP EP16788602.7A patent/EP3359665B1/en active Active
- 2016-10-07 EP EP16788603.5A patent/EP3359666B1/en active Active
- 2016-10-07 WO PCT/US2016/055915 patent/WO2017062722A2/en not_active Ceased
- 2016-10-07 SG SG11201802829YA patent/SG11201802829YA/en unknown
- 2016-10-07 PL PL16788602.7T patent/PL3359665T3/pl unknown
- 2016-10-07 MX MX2018004366A patent/MX2018004366A/es unknown
- 2016-10-07 IL IL258537A patent/IL258537B2/en unknown
- 2016-10-07 ES ES16788603T patent/ES3024209T3/es active Active
- 2016-10-07 CN CN201680072391.5A patent/CN108368505B/zh active Active
- 2016-10-07 SG SG11201802823VA patent/SG11201802823VA/en unknown
- 2016-10-07 AU AU2016335699A patent/AU2016335699A1/en not_active Abandoned
- 2016-10-07 PL PL16788603.5T patent/PL3359666T3/pl unknown
- 2016-10-07 CN CN202310124801.8A patent/CN116660127A/zh active Pending
- 2016-10-07 US US15/288,036 patent/US11635363B2/en active Active
- 2016-10-07 WO PCT/US2016/055918 patent/WO2017062724A1/en not_active Ceased
- 2016-10-07 IL IL258538A patent/IL258538B2/en unknown
- 2016-10-07 CA CA3001238A patent/CA3001238C/en active Active
-
2019
- 2019-04-23 US US16/392,174 patent/US20200018682A1/en active Pending
-
2022
- 2022-11-25 AU AU2022275507A patent/AU2022275507B2/en active Active
-
2023
- 2023-03-10 US US18/181,803 patent/US20230304913A1/en active Pending
-
2025
- 2025-09-04 AU AU2025226783A patent/AU2025226783A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUE071193T2 (hu) | Sejtek transzfekció utáni korai izolálása (EPIC) biologikumok elõállításához | |
| EP3858365C0 (en) | T CAR CELLS OPTIMIZED WITH GOLD | |
| EP3356420C0 (en) | MULTI-SPECIFIC ANTIBODIES | |
| DK3140393T3 (da) | Fremstillingsmetode for voksne leverstamceller | |
| HUE053101T2 (hu) | Javított T-sejt-készítmények | |
| PL3560953T3 (pl) | Komórka | |
| SI3294325T1 (sl) | Krepitev učinka car-izdelanih t celic s cepljenjem z nukleinsko kislino | |
| LT3126395T (lt) | Daugiaspecifiniai antikūnai | |
| HUE059158T2 (hu) | Eljárás pridopidin elõállítására | |
| HUE056002T2 (hu) | Eljárás cukrok elõállítására biomasszából | |
| HUE051839T2 (hu) | Elektrolit elõállítási eljárás | |
| HUE051968T2 (hu) | Elektrolit elõállítási eljárás | |
| DK3242903T3 (da) | Sammensætninger til at indføre nukleinsyre i celler | |
| DK3227435T3 (da) | Gammadelta-t-celleekspansionsprocedure | |
| HUE048744T2 (hu) | Eljárás etilénglikol elõállítására | |
| IL261710A (en) | Production of antigen-specific t-cells | |
| DK3365107T3 (da) | Cellekultur | |
| PL3294510T3 (pl) | Sposób wytwarzania paneli zawierających wgłębienia | |
| DK3166904T3 (da) | Fremgangsmåde til fremstilling af betonelementer | |
| LT3157504T (lt) | Kamienines ląsteles stimuliuojančios kompozicijos | |
| IL255500B (en) | Methods for assesing the purity of a mesenchymal stem cells preparation | |
| DK3631452T3 (da) | Assay til plasmacelleassocieret sygdom | |
| DK3262161T3 (da) | Rekombinante værtsceller til fremstilling af 3-hydroxypropionsyre | |
| EP3448986A4 (en) | CELL CULTURE | |
| DK3443110T3 (da) | Fermenteringsproces til fremstilling af maltosyl-isomalto-oligosaccharider (mimo) |